Cite

HARVARD Citation

    Villeneuve, N. et al. (n.d.). Anti-tumor necrosis factor alpha therapy, Adalimumab, in Rasmussen's encephalitis. European journal of paediatric neurology. pp. e8-. [Online]. 
  
Back to record